The fully developed phenotypes of metabolic diseases can be measured easily and tools have been developed for monitoring and controlling the development of metabolic diseases – e.g. the blood glucose level of diabetic patients is used as a biomarker to monitor the status of insulin function and to control medication. The gene discussed is INS; the disease is metabolic disease.